Molecular modelling and quantitative structure-activity relationship studies on the interaction of omeprazole with cytochrome P450 isozymes (Q74539246)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585098%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Molecular modelling and quantitative structure-activity relationship studies on the interaction of omeprazole with cytochrome P450 isozymes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585098%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

quantitative structure-activity relationship

1 reference

D F Lewis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585098%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

B G Lake

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585098%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585098%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585098%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585098%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585098%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

31-44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585098%20AND%20SRC:MED&resulttype=core&format=json

Omeprazole drug interaction studies

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Consideration of CASE predictions of genotoxic carcinogenesis for omeprazole, methapyrilene and azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

CYP1A1: friend or foe?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Assays of omeprazole metabolism as a substrate probe for human CYP isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

The interaction of omeprazole with rat liver cytochrome P450-mediated monooxygenase reactions in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Genotoxicity and cell proliferative activity of omeprazole in rat stomach mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Biochemistry and molecular biology of the human CYP2C subfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Identification of residues 99, 220, and 221 of human cytochrome P450 2C19 as key determinants of omeprazole activity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Inhibition of human liver cytochrome P-450 by omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Three-dimensional models of human and other mammalian microsomal P450s constructed from an alignment with P450102 (P450bm3)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Quantitative Structure-Activity Relationships in Substrates, Inducers, and Inhibitors of Cytochrome P4501 (CYP1)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Molecular modelling of CYP1A subfamily members based on an alignment with CYP102: rationalization of CYP1A substrate specificity in terms of active site amino acid residues

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102: structural studies on specific CYP2D6 substrate metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Molecular modelling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: rationalization of substrate specificity and site-directed mutagenesis experiments in the CYP2C subfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Omeprazole, cytochrome P450, and chemical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Lack of evidence of omeprazole genotoxicity in Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

The binding to oxidised cytochromes P-450 and inhibition of mixed-function oxidases by aryl-substituted benzimidazoles and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Omeprazole and the induction of human cytochrome P-450: a response to concerns about potential adverse effects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Interaction of omeprazole with DNA in rat tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Omeprazole: an exploration of its reported genotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

The pharmacology of the gastric acid pump: the H+,K+ ATPase

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Reconciling the magnitude of the microscopic and macroscopic hydrophobic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

In vivo and in vitro measurement of CYP2C19 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

The metabolism of tamoxifen by human cytochromes P450 is rationalized by molecular modelling of the enzyme-substrate interactions: potential importance to its proposed anti-carcinogenic/carcinogenic actions

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Selectivity of omeprazole inhibition towards rat liver cytochromes P450.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

Diazepam-omeprazole inhibition interaction: an in vitro investigation using human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2897%2900159-5

7 January 2021

10.1016/S0300-483X(97)00159-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585098%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585098%20AND%20SRC:MED&resulttype=core&format=json